Target intelligence / Profile preview

Membrane proteins and lipid environments

Molecular classification
Other
01

Overview

Membrane proteins and lipid environments refers to the complex structural and functional relationship between proteins embedded in or associated with biological membranes and the surrounding lipid bilayer (Gupta et al., 2017, Nature). Membrane proteins, including receptors, transporters, and enzymes, account for approximately 30% of the proteome and are the targets for over 50% of modern medicinal drugs (Overington et al., 2006, Nature Reviews Drug Discovery). The lipid environment, characterized by its composition, fluidity, and curvature, is not merely a passive solvent but actively modulates protein folding, stability, and signaling activity (Lee, 2004, Trends in Biochemical Sciences). Dysregulation of these interactions is implicated in various pathologies, including neurodegenerative disorders where lipid rafts influence amyloidogenic processing, and cancer, where altered membrane composition affects oncogenic signaling (Lagane and Gaudin, 2007, Seminars in Cell & Developmental Biology). While specific proteins within this environment are therapeutic targets, the "environment" itself represents a broad biological context rather than a single druggable entity. Therapeutic strategies often focus on specific membrane-bound receptors or channels, but emerging research explores how modulating the lipid environment itself can influence protein function (Contreras et al., 2011, Science). Consequently, understanding the interplay between membrane proteins and their lipid surroundings is crucial for optimizing drug binding and efficacy.

Other names
Membrane protein-lipid interactionsLipid-protein interfaceMembrane-associated proteinsLipid bilayer-protein complex
02

Mechanism of action

Drugs typically target specific membrane proteins whose activity is regulated by the lipid environment, or they may alter the physical properties of the lipid bilayer to indirectly modulate protein function (Contreras et al., 2011, Science).

03

Biological functions

Signal transductionMolecular transportCell adhesionEnergy transductionCell-cell communication
04

Disease associations

CancerNeurodegenerative diseaseMetabolic diseaseInfectious diseaseCardiovascular disease
05

Safety considerations

Lack of specificitySystemic toxicity due to membrane disruptionComplex pharmacokinetics in lipid-rich tissues

Beyond the preview

Go deeper on Membrane proteins and lipid environments.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane proteins and lipid environments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call